We have located links that may give you full text access.
A strategy in wastewater treatment process for significant reduction of excess sludge production.
A novel wastewater treatment process (S-TE PROCESS) with significantly reduced production of excess sludge has been developed. The process consists of two different stages, one for a biological wastewater treatment and the other for a thermophilic aerobic digestion of the resulting sludge. A portion of return sludge from the wastewater treatment step is injected into a thermophilic aerobic sludge digester (TASD), in which the injected sludge is solubilized by the action of thermophilic aerobic bacteria. The solubilized sludge is returned to the aeration tank in the wastewater treatment step for its further degradation. Pilot-scale facilities of the S-TE process and the conventional activated sludge process as a control, both treating the same industrial wastewater, were comparatively operated for totally 270 days. As a result, 93% reduction in overall excess sludge production was achieved in the S-TE operation. The SS solubilization rate in TASD was stable at around 30%. Only a slight increase in the effluent SS and TOC concentrations was observed compared with those of the control facility. Otherwise the removal efficiency of TOC was approximately 95% for both plants. A full-scale plant treating domestic sewage was operated for three years, showing 75% reduction of overall excess sludge production. It was concluded that the new process was feasible.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app